Category: News
-
Ocugen Clinical Trial Could Lead to Breakthrough One-Time Treatment for Advanced Dry Macular Degeneration
NORTHAMPTON, Ma., Dec. 19, 2023 — The American Macular Degeneration Foundation received news that the first patient has been dosed in a safety and efficacy clinical trial of a one-time gene therapy treatment for advanced dry macular degeneration (dry AMD), also known as Geographic Atrophy (GA). What’s exciting about this trial is that, if successful,…
Advocacy for a Cure: How AMDF is Making a Difference in Washington DC
September 2023 The American Macular Degeneration Foundation participated in Capitol Hill events hosted by the Alliance for Eye and Vision Research (AEVR) for the 5th year in a row. The purpose of these events is to raise awareness about the need for increased eye research funding to keep pace with the cost of meaningful eye…
New Treatments for Macular Degeneration on the Horizon
In addition to some exciting new treatments now FDA-approved for the treatment of different stages of macular degeneration (published in the current issue of our print newsletter, In the Spotlight, several new treatment options for macular degeneration are on the horizon. Emerging Approaches to AMD Treatments The process of capturing light and transforming it into…
New Documentary on Living with Macular Degeneration
Losing Sight, Finding Hope: Living with Macular Degeneration The new documentary, Losing Sight, Finding Hope: Living with Macular Degeneration, from The American Macular Degeneration Foundation, and created by filmmaker Nick Czerula, premieres on YouTube on: Monday, March 20, 2023 at 8PM EST View the teaser below: How to Watch The full documentary, Losing Sight, Finding…
Breaking News – FDA Approves First Geographic Atrophy Treatment, SYFOVRE
A groundbreaking, new frontier in macular degeneration treatment has been announced! With the FDA’s approval of Syfovre™, for the first time there’s hope to preserve sight for millions of patients with the advanced stage of dry macular degeneration (dry AMD), called geographic atrophy (GA). “This is extraordinary news,” said Chip Goehring, Founder and President of…
AMDF Premieres New Film on ‘Living with Macular Degeneration’ for AMD Awareness Month 2023
February 8, 2023 As part of AMD Awareness Month 2023, The American Macular Degeneration Foundation announces the premiere of: Life with Macular DegenerationPatient Stories Mary Toss: The Perseverance of Spirit About the Film In this honest, short documentary, Mary Toss shares her personal story of living with macular degeneration. She reflects on the reality of…
Coronavirus and Your Macular Degeneration Care
**Important Update as of 2/5/2021 Since the publishing of these guidelines in March of 2020, information has come to light regarding AMD patients’ risk of more severe illness if they contract COVID-19. Please continue to follow the guidelines below in regards to your eye care, follow the CDC recommended protocols to reduce your risk of…
Cutting Edge Research Grants Announced by The American Macular Degeneration Foundation, Co-funded with Research to Prevent Blindness
The American Macular Degeneration Foundation (AMDF), in partnership with Research to Prevent Blindness (RPB), has announced the recipients of the RPB/AMDF Catalyst Awards for Innovative Research Approaches for Age-Related Macular Degeneration, which provide seed money for high-risk/high-gain AMD research into both dry and wet forms of the disease. Each grantee will receive $300,000, payable across…
AMDF In the Trenches: Stimulating Research Through New Grants and Partnerships
Through a growing portfolio of research grants and creative partnerships with other eye research funders, the American Macular Degeneration Foundation (AMDF) is finding ways to efficiently leverage its resources and accelerate the development of promising approaches to improve the lives of age-related macular degeneration (AMD) patients. At AMDF, we have been hearing from researchers that…